热门科学

CAR-T

论题描述： This hub is created to discuss CAR-T cell therapy for cancer treatment such as leukemia, large B cell lymphoma.

热门最新活跃 Reviewer Roulette

置顶内容上次更新 2年前

CAR-T therapies are progressing to the market at a much faster rate. Novartis just received approval from Australian authorities to make it's CAR-T therapy available to all eligible patients. Additionally, Bristol-Myers Squibb also received FDA approval in the US for it's CAR-T cell therapy for adults with relapsed large B-cell lymphoma. Kite Pharma already has FDA approved CAR-T cell therapy for the same in the market for a while now. Seems like all major Pharma/Biotech companies will soon embrace CAR-T's, leading to more competition and hopefully making these therapies more affordable as a result. Below is a link to the latest advancements in CAR-T's by biopharma reporter.

链接: https://www.biopharma-reporter.com/Article/2021/02/15/Scientific-breakthroughs-approvals-Latest-CAR-T-cell-therapy-related-developments#:~:text=Earlier%20this%20month%2C%20the%20US,directed%20CAR%20T%2Dcell%20immunotherapy.

Archived Board

动态留言

CAR-T's discussion

置顶内容

Here is a link to a very interesting Nature review article on programming CAR-T cells to kill cancer!

链接: https://www.nature.com/articles/s41551-018-0235-9

归档留言版	归档日期	讨论数
CAR-T's discussion		12

4 个成员: 创建者

Harwinder

Patrick

Neil

Wai

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

置顶内容 上次更新 2年前

Archived Board

CAR-T's discussion

Publish scientific posters with Peeref

Create your own webinar

置顶内容上次更新 2年前